Hemogenyx Pharmaceuticals (HEMO) News Today → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free HEMO Stock Alerts GBX 1.53 +0.07 (+5.07%) (As of 04:27 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 10:19 PM | investing.comHemogenyx Pharmaceuticals PLC (HEMO)April 29, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023April 25, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Final ResultsApril 15, 2024 | msn.comSMALL CAP IDEA: Why investors should add Hemogenyx Pharmaceuticals to their watchlistMarch 30, 2024 | msn.comCompare with Oxurion NV (0G99)March 28, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Total Voting RightsMarch 13, 2024 | proactiveinvestors.comAlbo unveils ambitious $4 billion plan to overhaul remote housing in the Northern TerritoryMarch 12, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals discusses successful £3.5M capital raise as it advances HEMO-CAR-T programFebruary 29, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Placing to Raise US$4.2 millionFebruary 21, 2024 | lse.co.ukLondon pre-open: Stocks to nudge up; HSBC in focusFebruary 20, 2024 | finance.yahoo.comLung Cancer Research Foundation and American Lung Cancer Screening Initiative Join Forces for "Plus One" CampaignFebruary 20, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals achieves breakthrough with HEMO-CAR-T program, CBR platformFebruary 16, 2024 | lse.co.ukHemogenyx shares rise on potential for CBR to treat brain diseasesFebruary 16, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces CBR Brain DeliveryFebruary 14, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces CBR Intranasal DeliveryFebruary 9, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces FDA Consents to Phase I Trials of HEMO-CAR-TFebruary 2, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces the Approval and Issuance of U.S. Conditioning PatentJanuary 16, 2024 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Submission of Complete Response to Clinical HoldJanuary 8, 2024 | lse.co.ukHemogenyx Pharmaceuticals completes process qualification runNovember 28, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Placing to Raise £534,375November 27, 2023 | lse.co.ukHemogenyx shares up as says CBR platform a potential cancer treatmentNovember 27, 2023 | marketwatch.comHemoGenyx Says CBR Platform Could Potentially Be Used for Cancer TreatmentNovember 27, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces CBR Expanded to Treatment of CancerNovember 15, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Lentivirus Re-manufacturing CompletedSeptember 28, 2023 | lse.co.ukEARNINGS: Dar Global profit multiplies, Hemogenyx loss widensSeptember 18, 2023 | seekingalpha.comPrevail Partners to invest in Hemogenyx PharmaceuticalsSeptember 18, 2023 | marketwatch.comHemogenyx Stock Rises on Premium Share SubscriptionSeptember 14, 2023 | marketwatch.comHemogenyx Pharmaceuticals Says FDA Accepted Plans to Address Leukemia Treatment ConcernsSeptember 14, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC - Clinical Hold Lift Plan is accepted by FDASeptember 8, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces CBR Patent Application UpdateAugust 28, 2023 | finance.yahoo.comIs Hemogenyx Pharmaceuticals (LON:HEMO) In A Good Position To Deliver On Growth Plans?July 10, 2023 | lse.co.ukHemogenyx says Hemo-Car-T treatment placed on clinical hold by US FDAJuly 10, 2023 | marketwatch.comHemogenyx Pharmaceuticals Addresses FDA Concern on Leukemia Treatment; Shares RiseJuly 10, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Full FDA Review for HEMO-CAR-T INDJune 2, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Clinical Hold on IND for HEMO-CAR-TJune 2, 2023 | marketwatch.comHemogenyx Pharmaceuticals Shares Fall After FDA Puts Leukemia Treatment Application on HoldMay 9, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Submission of IND for HEMO-CAR-TMay 6, 2023 | bizjournals.comNew York Pharmaceuticals NewsApril 28, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Final Results for the Year Ended 31 December 2022April 28, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Equity Incentive Pool Increase and Option GrantMarch 23, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Analytical Release Tests CompletedMarch 20, 2023 | finance.yahoo.comWe're Not Very Worried About Hemogenyx Pharmaceuticals' (LON:HEMO) Cash Burn RateJanuary 26, 2023 | marketwatch.comHemogenyx Pharmaceuticals Shares Fall on Discounted Fund RaisingJanuary 26, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Placing to Raise £4,056,250January 25, 2023 | lse.co.ukHemogenyx Share News (HEMO)January 23, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T 3rd Process Qualification Run CompletedJanuary 9, 2023 | marketwatch.comHemoGenyx Shares Rise After Target Protein Discovery for Viral TreatmentJanuary 9, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces Single CBR Can Treat Multiple VirusesJanuary 4, 2023 | finance.yahoo.comHemogenyx Pharmaceuticals PLC Announces HEMO-CAR-T Process Qualification Run CompletedDecember 12, 2022 | finance.yahoo.comHemogenyx Pharmaceuticals PLC - HEMO-CAR-T First PQ Run Completed Get Hemogenyx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HEMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. HEMO Media Mentions By Week HEMO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HEMO News Sentiment▼0.000.43▲Average Medical News Sentiment HEMO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HEMO Articles This Week▼10▲HEMO Articles Average Week Get Hemogenyx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HEMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OKYO Pharma News Ondine Biomedical News Oncimmune News OptiBiotix Health News Destiny Pharma News Synairgen News C4X Discovery News ImmuPharma News BiVictriX Therapeutics News Roquefort Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HEMO) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss RatingsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
